Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease

Fig. 1

Predicted versus observed major adverse cardiovascular events (MACE) 4-year rates of the simplified and extended risk scores based on deciles of predicted risk. MACE is a composite of first nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death

Back to article page